Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity
.jpeg)
Nanoscale drug delivery vehicles have been harnessed extensively as carriers for cancer chemotherapeutics. However, traditional pharmaceutical approaches for nanoformulation have been a challenge with molecules that exhibit incompatible physicochemical properties, such as platinum-based chemotherapeutics. Here we propose a paradigm based on rational design of active molecules that facilitate supramolecular assembly in the nanoscale dimension. Using cisplatin as a template, we describe the synthesis of a unique platinum (II) tethered to a cholesterol backbone via a unique monocarboxylato and O→Pt coordination environment that facilitates nanoparticle assembly with a fixed ratio of phosphatidylcholine and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino (polyethylene glycol)-2000].
To continue reading about this article, you can access it here.
Recommended Reading
A 3D co-culture system for high-throughput screening of anti-angiogenic and anti-tumorigenic combination therapies
Read More
Preferential Treatment Policies: A Perspective into Affirmative Action in India and the United States
Read More
P2-133 Assembly of filamentous tau aggregates in conditional transfectants of human neuronal lineage that overproduce wild-type human brain tau in triple isoforms
Read More
%20(1).webp)